Skip to main content
PulseWire News
HealthHealth Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee is scheduled to make decisions regarding vaccinations against COVID-19 and hepatitis B, amid controversies surrounding changes to longstanding health guidelines.

RFK Jr.'s Vaccine Advisory Committee Faces Controversy with Proposed Changes

Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee discusses vaccination recommendations for COVID-19, hepatitis B, and chickenpox, amidst rising concerns from health advocates about potential rollbacks in vaccination protocols.

Source: AP2 min read

In brief

The Advisory Committee on Immunization Practices, under Health Secretary Robert F. Kennedy Jr., convenes to deliberate on new recommendations for COVID-19 and other vaccines. Proposals may include a rollback on the hepatitis B vaccine administered at birth, raising concerns among health experts who signal that such changes could negatively impact childhood vaccination rates. The meeting reflects broader tensions in public health policy amid rising skepticism towards vaccinations.

ATLANTA (PulseWire) — The new vaccine advisory committee led by Health Secretary Robert F. Kennedy Jr. will convene on Thursday for a two-day session focused on COVID-19, hepatitis B, and chickenpox vaccinations.

The committee is expected to vote on proposals regarding hepatitis B and a combined vaccine for measles, mumps, rubella, and chickenpox, however, specific items on the agenda have not been disclosed by the Department of Health and Human Services.

Emerging reports suggest that the committee might consider rolling back a long-standing practice of administering the hepatitis B vaccine at birth, a move supported by numerous public health experts including the American Academy of Pediatrics.

Dr. Mysheika Roberts, a health official in Columbus, Ohio expressed concerns about decreasing rates of liver disease in children due to the hepatitis B vaccine. Roberts, who was originally on the vaccine panel but removed by Kennedy, questioned the rationale for altering a program that has shown considerable success.

Meanwhile, the committee's chair, Martin Kulldorff, has mentioned possible restrictions on the MMRV combination vaccine for children younger than four due to rare associations with febrile seizures that occurred after the first dose.

Historically, the Advisory Committee on Immunization Practices has met to review these recommendations, with the CDC typically accepting their guidance. But in a controversial move, Kennedy dismissed the previous 17-member panel, replacing it with a group that includes individuals known for voicing skepticism towards vaccines.

This shift has provoked alarm among medical professionals, particularly following announcements earlier this year when Kennedy removed COVID-19 vaccinations from CDC recommendations for healthy children.

In recent times, multiple states have enacted policies to facilitate residents' access to vaccines, ensuring COVID-19 vaccinations are available at pharmacies without prescriptions. Wisconsin recently joined this trend, promoting adherence to guidance from national health organizations during an executive order signed by Governor Tony Evers.

The advisory committee is scheduled to finalize its recommendations on COVID-19 vaccinations by Friday, as national debates around vaccination continue to intensify, reflecting broader societal tensions around public health policy.

Topics

More on this story